Vdyne, Inc.
Clinical trials sponsored by Vdyne, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart valve device offers hope for patients with leaky tricuspid valve Results expected Nov 2026 (estimated)
- New heart valve replacement could spare patients from major surgery Results expected Dec 2026 (estimated)
-
New heart valve device offers hope for patients with leaky tricuspid valve
Disease control Recruiting nowThis study tests a new device called the VDyne System to replace the tricuspid valve in people with severe tricuspid regurgitation (a leaky heart valve). The goal is to see if the device is safe and can improve symptoms, exercise ability, and quality of life. About 30 adults with…
Sponsor: VDyne, Inc. • Aim: Disease control
Last updated Sep 21, 2026 22:00 UTC
-
New heart valve replacement could help thousands avoid Open-Heart surgery
Disease control Recruiting nowThis study tests a new device called the VDyne System, which is placed inside the heart through a tube in a blood vessel to replace a leaky tricuspid valve. The trial will include 730 people with severe symptoms who have not improved with medication. Researchers will compare the …
Sponsor: VDyne, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New heart valve replacement could spare patients from major surgery
Disease control Recruiting nowThis study tests a new device called the VDyne System, which is placed through a tube in a blood vessel to replace the tricuspid valve in the heart. It is for people with severe tricuspid regurgitation, a condition where the valve does not close properly, causing blood to leak ba…
Sponsor: VDyne, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC